| 000 | 01801 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250512044849.0 | ||
| 264 | 0 | _c19870930 | |
| 008 | 198709s 0 0 eng d | ||
| 022 | _a0171-7111 | ||
| 024 | 7 |
_a10.1007/978-3-642-71213-5_81 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSchaison, G | |
| 245 | 0 | 0 |
_aIntermediate-risk childhood acute lymphoblastic leukemias: amsacrine + cytosine arabinoside versus intermediate-dose methotrexate for consolidation, and 6-mercaptopurine + methotrexate + vincristine versus monthly pulses for maintenance. _h[electronic resource] |
| 260 |
_bHaematology and blood transfusion _c1987 |
||
| 300 |
_a461-5 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 |
_aAmsacrine _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aCytarabine _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia, Lymphoid _xdrug therapy |
| 650 | 0 | 4 |
_aMercaptopurine _xadministration & dosage |
| 650 | 0 | 4 |
_aMethotrexate _xadministration & dosage |
| 650 | 0 | 4 | _aRandom Allocation |
| 650 | 0 | 4 | _aRisk |
| 650 | 0 | 4 |
_aVincristine _xadministration & dosage |
| 700 | 1 | _aLeverger, G | |
| 700 | 1 | _aBancillon, A | |
| 700 | 1 | _aMarty, M | |
| 700 | 1 | _aOlive, D | |
| 700 | 1 | _aCornu, G | |
| 700 | 1 | _aGriscelli, C | |
| 700 | 1 | _aLemerle, S | |
| 700 | 1 | _aHarousseau, J L | |
| 700 | 1 | _aBonnet, M | |
| 773 | 0 |
_tHaematology and blood transfusion _gvol. 30 _gp. 461-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/978-3-642-71213-5_81 _zAvailable from publisher's website |
| 999 |
_c3310966 _d3310966 |
||